Aseptic meningitis and abducens nerve palsy as a serious side effect of high dose intravenous immunoglobulin used in a patient with renal transplantation
Authors:
- 23 July 2008
- journal article
- case report
- Published by Wiley in Transplant Infectious Disease
- Vol. 10 (4) , 294-297
Abstract
Immune globulin intravenous (human) (IGIV) is effective in the treatment of various autoimmune and inflammatory disorders. Recently, high‐dose IGIV 2 g/kg has been utilized in the treatment of antibody‐mediated rejection in solid organ transplantation. We report a renal transplant recipient who developed aseptic meningitis and diplopia from abducens nerve (cranial nerve VI) palsy following IGIV administration for antibody‐mediated rejection. Potential mechanisms of the IGIV‐related aseptic meningitis are elaborated. Clinicians should be aware of aseptic meningitis and cranial nerve palsy as an adverse reaction to IGIV exposure and monitor for its signs and symptoms.Keywords
This publication has 14 references indexed in Scilit:
- Therapy With Plasmapheresis and Intravenous Immunoglobulin for Acute Humoral Rejection in Kidney TransplantationTransplantation Proceedings, 2005
- Utility of Intravenous Immune Globulin in Kidney Transplantation: Efficacy, Safety, and Cost ImplicationsAmerican Journal of Transplantation, 2003
- Capillary C4d Deposition as a Marker of Humoral Immunity in Renal Allograft RejectionJournal of the American Society of Nephrology, 2002
- Drug-Induced Aseptic MeningitisDrug Safety, 2000
- Acquired Binocular Horizontal DiplopiaMayo Clinic Proceedings, 1999
- Spontaneous recovery rates for unilateral sixth nerve palsiesEye, 1995
- Aseptic Meningitis and Intravenous Immunoglobulin TherapyAnnals of Internal Medicine, 1994
- Aseptic Meningitis Associated with High-Dose Intravenous Immunoglobulin Therapy: Frequency and Risk FactorsAnnals of Internal Medicine, 1994
- Acute Bacterial Meningitis in Adults -- A Review of 493 EpisodesNew England Journal of Medicine, 1993
- A method for estimating the probability of adverse drug reactionsClinical Pharmacology & Therapeutics, 1981